- Home
- HLN
HLN
Haleon plc (Each representing two)
as 07-26-2024 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Haleon plc (Each representing two) HLN prepares to release earnings report on 01 Aug 2024.
| Founded: | 2022 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $9.50 | AVG Volume (30 days): | 4.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.29 | EPS Growth: | -8.87 |
| 52 Week Low/High: | $7.70 - $9.28 | Next Earning Date: | 08-01-2024 |
| Revenue: | $14,306,329,114 | Revenue Growth: | 14.25% |
| Revenue Growth (this year): | 4.42% | Revenue Growth (next year): | 4.38% |
Latest Haleon plc (Each representing two) News
HLN Breaking Stock News: Dive into HLN Ticker-Specific Updates for Smart Investing
Zacks
9 days ago
HLN vs. LMAT: Which Stock Is the Better Value Option?
Zacks
16 days ago
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
Zacks
a month ago
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Morningstar Research
a month ago
Analyst Report: Haleon plc
MT Newswires
a month ago
Dr. Reddy's Laboratories to Acquire Nicotinell Portfolio From Haleon
Business Wire
a month ago
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
Argus Research
2 months ago
Analyst Report: Haleon plc
Argus Research
2 months ago
Market Digest: NVO, NJR, PPL, SPH, APTV, HLN
Compare HLN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HLN Haleon plc (Each representing two) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.